"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."

Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial micro balloon catheter for hepatocellular carcinoma: Technical and safety considerations

  -  

Results

A total of 31 patients received 70 sessions of B-TACE using a 1.8-Fr tip micro balloon catheter Occlusafe®.

​Level of B-TACE

​Sessions (n)

​Sub-sub segmental​11
​Sub segmental​35
​Segmental​14
​Lobar​5
​Right inferior phrenic artery​5

Technical Success

The overall technical success rate was 99% (69 out of 70 sessions).

As procedural complications, rupture of the micro balloon (n = 3) and aneurysmal dilatation at the site of balloon occlusion (n = 2) were encountered.

Blood parameters

There were no significant differences in any parameters between blood biochemical examination before and between two to four weeks after the procedure.

Conclusion

A 1.8-Fr tip micro balloon catheter Occlusafe® enables selective catheterization in patients with HCC and B-TACE using the 1.8-Fr tip micro balloon catheter is a safe procedure